Autoimmune Diseases  >>  Careram (iguratimod)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Careram (iguratimod) / Eisai, R-Pharm
NCT01850966: Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Completed
N/A
2747
Japan
Iguratimod
Eisai Co., Ltd.
Rheumatoid Arthritis
04/14
04/14

Download Options